Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Introgen Therapeutics -- Ignore unavailable to you. Want to Upgrade?

To: zeta1961 who wrote (513)	3/13/2006 12:58:13 PM
From: Jibacoa	Read Replies (1) \| Respond to of 802

About the CC: Press Release Source: Introgen Therapeutics, Inc. Introgen Therapeutics, Inc. Fourth Quarter 2005 Earnings Conference Call Monday March 13, 12:00 pm ET AUSTIN, Texas, March 13 /PRNewswire-FirstCall/ -- Introgen Therapeutics, Inc. (Nasdaq: INGN - News), a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases, will hold its quarterly conference call to discuss fourth quarter results on Wednesday, March 15, 2006, at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). This call is being webcast by Thomson/CCBN and can be accessed at Introgen's Web site at: introgen.com The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at earnings.com , Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents: streetevents.com